Seiji Arai

1.1k total citations
69 papers, 732 citations indexed

About

Seiji Arai is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Seiji Arai has authored 69 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 24 papers in Molecular Biology and 21 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Seiji Arai's work include Prostate Cancer Treatment and Research (32 papers), Hormonal and reproductive studies (20 papers) and Prostate Cancer Diagnosis and Treatment (14 papers). Seiji Arai is often cited by papers focused on Prostate Cancer Treatment and Research (32 papers), Hormonal and reproductive studies (20 papers) and Prostate Cancer Diagnosis and Treatment (14 papers). Seiji Arai collaborates with scholars based in Japan, United States and China. Seiji Arai's co-authors include Yasuhiro Shibata, Steven P. Balk, Kazuhiro Suzuki, Yoshitaka Sekine, Sen Chen, Seijiro Honma, Yoshiyuki Miyazawa, Kazuto Ito, Hidekazu Koike and Hiroshi Matsui and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Seiji Arai

63 papers receiving 721 citations

Peers

Seiji Arai
Soum D. Lokeshwar United States
Tony T. Wu Taiwan
Shuai Gao United States
Kristine M. Wadosky United States
Gary J. Smith United States
Stephen G. Patterson United States
Seiji Arai
Citations per year, relative to Seiji Arai Seiji Arai (= 1×) peers Suman Verma

Countries citing papers authored by Seiji Arai

Since Specialization
Citations

This map shows the geographic impact of Seiji Arai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiji Arai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiji Arai more than expected).

Fields of papers citing papers by Seiji Arai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seiji Arai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiji Arai. The network helps show where Seiji Arai may publish in the future.

Co-authorship network of co-authors of Seiji Arai

This figure shows the co-authorship network connecting the top 25 collaborators of Seiji Arai. A scholar is included among the top collaborators of Seiji Arai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seiji Arai. Seiji Arai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gui, Fu, Baishan Jiang, Jie Jiang, et al.. (2025). Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer. Science Advances. 11(17). eadu0847–eadu0847. 2 indexed citations
3.
Arai, Seiji, Yanfei Gao, Ziyang Yu, et al.. (2024). A carboxy-terminal ubiquitylation site regulates androgen receptor activity. Communications Biology. 7(1). 25–25. 2 indexed citations
4.
Miyazawa, Yoshiyuki, Toshiyuki Nakamura, Yutaka Takezawa, et al.. (2023). A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC‐MS/MS. The Prostate. 83(8). 759–764. 2 indexed citations
5.
Arai, Seiji, Yoshiyuki Miyazawa, Masashi Nomura, et al.. (2023). Predictive models of long‐term survival outcomes following radical cystectomy. Cancer Medicine. 12(23). 21118–21128. 2 indexed citations
6.
Wang, Keshan, Fen Ma, Seiji Arai, et al.. (2023). WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth. Cancer Research. 83(7). 1016–1030. 26 indexed citations
7.
Arai, Seiji, Mai Kato, Yoshiyuki Miyazawa, et al.. (2022). Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cells. Biochemical and Biophysical Research Communications. 628. 76–83. 2 indexed citations
8.
Miyazawa, Yoshiyuki, Yoshitaka Sekine, Seiji Arai, et al.. (2022). Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin. IJU Case Reports. 6(1). 37–40. 4 indexed citations
9.
Liang, Jiaqian, Liyang Wang, Mannan Nouri, et al.. (2021). Androgen receptor splice variant 7 functions independently of the full length receptor in prostate cancer cells. Cancer Letters. 519. 172–184. 16 indexed citations
10.
Guo, Haiyang, Yiming Wu, Mannan Nouri, et al.. (2021). Androgen receptor and MYC equilibration centralizes on developmental super-enhancer. Nature Communications. 12(1). 7308–7308. 42 indexed citations
11.
Einstein, David J., Seiji Arai, Carla Calagua, et al.. (2021). Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors. JCO Precision Oncology. 1514–1522. 8 indexed citations
12.
Arai, Seiji, Andreas Varkaris, Mannan Nouri, et al.. (2020). MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation. eLife. 9. 37 indexed citations
13.
Arai, Seiji, Oliver Jonas, Matthew A. Whitman, et al.. (2018). Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis. Clinical Cancer Research. 24(21). 5458–5470. 50 indexed citations
14.
Russo, Joshua W., Ce Gao, Swati S. Bhasin, et al.. (2018). Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer. Cancer Research. 78(22). 6354–6362. 43 indexed citations
15.
Shibata, Yasuhiro, et al.. (2014). Clinical Outcomes of Microscopic Subinguinal Varicocelectomy for Male Infertility and Scrotal Pain Patients. The Kitakanto Medical Journal. 64(1). 31–35. 1 indexed citations
16.
Nakaya, Naoki, et al.. (2014). Psychosocial Longitudinal Study Profile and Distress of Couples in Relation to the Conduct of Prostate Biopsy. Japanese Journal of Clinical Oncology. 44(5). 463–471. 9 indexed citations
17.
Shibata, Yasuhiro, Seiji Arai, & Seijiro Honma. (2014). Methodological approach to the intracrine study and estimation of DHEA and DHEA-S using liquid chromatography–tandem mass spectrometry (LC–MS/MS). The Journal of Steroid Biochemistry and Molecular Biology. 145. 193–199. 13 indexed citations
18.
Arai, Seiji, Yoshimichi Miyashiro, Yasuhiro Shibata, et al.. (2009). New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography–tandem mass spectrometry. Steroids. 75(1). 13–19. 24 indexed citations
19.
Shibata, Yasuhiro, et al.. (2006). Positive effect of prostaglandin on regulation of prostatic blood flow. Urology. 68(3). 682–686. 1 indexed citations
20.
Arai, Seiji, et al.. (1970). Photoconductive Properties of Zinc Oxide. Journal of the Japan Society of Colour Material. 43(2). 76–86.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026